US$ 24.11
glp-1 bcbs Blue Cross Blue Shield plans reverse course on coverage Why we are changing coverage
Description
Physician-formulated for GLP-1 users

You may not edit, resell, or re-distribute.Please contact me if you have any problems
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become one of the most popular medications for patients with diabetes and obesity
Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

World Health Organization
